Your browser doesn't support javascript.
loading
Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy-A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study.
Spathas, Nikolaos; Goussia, Anna C; Koliou, Georgia-Angeliki; Gogas, Helen; Zagouri, Flora; Batistatou, Anna; Charchanti, Antonia V; Papoudou-Bai, Alexandra; Bobos, Mattheos; Chrisafi, Sofia; Chatzopoulos, Kyriakos; Kostopoulos, Ioannis; Koletsa, Triantafyllia; Arapantoni, Petroula; Pectasides, Dimitrios; Galani, Eleni; Koutras, Angelos; Zarkavelis, George; Saloustros, Emmanouil; Bafaloukos, Dimitrios; Karanikiotis, Charisios; Bompolaki, Iliada; Aravantinos, Gerasimos; Psyrri, Amanda; Razis, Evangelia; Koumarianou, Anna; Res, Eleni; Linardou, Helena; Fountzilas, George.
Afiliação
  • Spathas N; Fourth Oncology Department, Metropolitan Hospital, 18547 Athens, Greece.
  • Goussia AC; Department of Pathology, Ioannina University Hospital, 45500 Ioannina, Greece.
  • Koliou GA; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, 11526 Athens, Greece.
  • Gogas H; First Department of Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, 11527 Athens, Greece.
  • Zagouri F; Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, 11528 Athens, Greece.
  • Batistatou A; Department of Pathology, Ioannina University Hospital, 45500 Ioannina, Greece.
  • Charchanti AV; Department of Pathology, Ioannina University Hospital, 45500 Ioannina, Greece.
  • Papoudou-Bai A; Department of Pathology, Ioannina University Hospital, 45500 Ioannina, Greece.
  • Bobos M; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece.
  • Chrisafi S; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece.
  • Chatzopoulos K; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece.
  • Kostopoulos I; Department of Pathology, School of Health Sciences, Faculty of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Koletsa T; Department of Pathology, School of Health Sciences, Faculty of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Arapantoni P; Department of Pathology, Henry Dunant Hospital, 11526 Athens, Greece.
  • Pectasides D; Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, 11527 Athens, Greece.
  • Galani E; Second Department of Medical Oncology, Metropolitan Hospital, 18547 Piraeus, Greece.
  • Koutras A; Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, 26504 Patras, Greece.
  • Zarkavelis G; Department of Medical Oncology, Medical School, University of Ioannina, 45500 Ioannina, Greece.
  • Saloustros E; Department of Oncology, University Hospital of Larissa, 41334 Larissa, Greece.
  • Bafaloukos D; First Department of Medical Oncology, Metropolitan Hospital, 18547 Piraeus, Greece.
  • Karanikiotis C; Department of Medical Oncology, 424 Army General Hospital, 56429 Thessaloniki, Greece.
  • Bompolaki I; Oncology Department, General Hospital of Chania, 73300 Crete, Greece.
  • Aravantinos G; Second Department of Medical Oncology, Agii Anargiri Cancer Hospital, 14564 Athens, Greece.
  • Psyrri A; Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, 12462 Athens, Greece.
  • Razis E; Third Department of Medical Oncology, Hygeia Hospital, 15123 Athens, Greece.
  • Koumarianou A; Hematology-Oncology Unit, Fourth Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens School of Medicine, 12462 Athens, Greece.
  • Res E; Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, 14564 Athens, Greece.
  • Linardou H; Fourth Oncology Department, Metropolitan Hospital, 18547 Athens, Greece.
  • Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece.
Cancers (Basel) ; 14(22)2022 Nov 16.
Article em En | MEDLINE | ID: mdl-36428728
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Grécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Grécia